You just read:

TAXIS Pharmaceuticals Demonstrates Synergistic Efficacy Against MRSA And Low Resistance Frequency With TXA709/Cefdinir Combination

News provided by

TAXIS Pharmaceuticals

Sep 18, 2015, 03:05 ET